Comparison of long-term outcomes in a 10-year experience of robotic cystectomy vs. open cystectomy
- 23 November 2020
- journal article
- research article
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 15 (5) , 773-780
Abstract
To compare the outcomes of robotic-assisted (RARC) vs. open radical cystectomy (ORC) at a single academic institution. We retrospectively identified patients undergoing radical cystectomy for urothelial carcinoma of the bladder at our institution from 2007 to 2017. Data collected included age, sex, Body Mass Index (BMI), Charlson Age-Adjusted Comorbidity Index (CCI), final pathologic stage, surgical margins, lymph-node yield, estimated blood loss (EBL), 90-day complication rate, and length of stay (LOS). We evaluated overall survival (OS) and recurrence-free survival (RFS). Multivariable Cox proportional hazard models were used to adjust for covariates. We identified 232 patients (73 RARC, 159 ORC) who underwent radical cystectomy. Patients who underwent RARC were older (71.8 vs. 67.5, p < 0.05) and had higher CCI scores (6.2 vs. 5.3, p < 0.05). In comparing perioperative outcomes, RARC patients had lower EBL (500 vs. 850, p < 0.01), lower blood transfusion rate (p < 0.01), and lower lymph-node yield (12 vs. 20, p < 0.01), and higher ICU admission rate (29% vs. 16% p < 0.01). There was no difference in BMI (p = 0.93), sex (p = 0.28), final pathological stage (p = 0.35), positive surgical margins (p = 0.47), complications (p = 0.58), or LOS (p = 0.34). Kaplan–Meier analysis showed no difference in OS (p = 0.26) or RFS (p = 0.86). There was no difference in restricted mean survival time for OS (53 vs. 56 months, p = 0.81) or for RFS (65 vs. 64 months, p = 0.90). Cox multivariate regression models showed that surgical approach does not have a significant impact on OS (p = 0.46) or RFS (p = 0.35). Our study indicates that in our 10-year experience, patients undergoing there was no difference between RARC and ORC patients with respect to OS and RFS despite being older and having more comorbidities. Our work supports the importance of patient selection to optimize outcomes.Keywords
This publication has 24 references indexed in Scilit:
- Trends in Operative Caseload and Mortality Rates after Radical Cystectomy for Bladder Cancer in England for 1998–2010European Urology, 2015
- Radical Cystectomy: Open vs Robotic ApproachJournal of Urology, 2015
- Robotic vs. open radical cystectomy in bladder cancer: A systematic review and meta-analysisEuropean Journal of Surgical Oncology, 2014
- A Randomized Trial of Robot-Assisted Laparoscopic Radical CystectomyNew England Journal of Medicine, 2014
- Robot‐assisted radical cystectomy ( RARC ) with intracorporeal neobladder – what is the effect of the learning curve on outcomes?BJU International, 2013
- Robotic Versus Open Radical Cystectomy: Identification of Patients who Benefit from the Robotic ApproachJournal of Endourology, 2013
- The economics of robotic cystectomy: cost comparison of open versus robotic cystectomyBJU International, 2011
- Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research ConsortiumJournal of Urology, 2006
- Standardization of Radical Cystectomy and Pelvic Lymph Node Dissection for Bladder Cancer: A Collaborative Group ReportJournal of Urology, 2004
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987